The Global Proton Therapy Market size is expected to reach $963.6 million by 2028, rising at a market growth of 12.5% CAGR during the forecast period.
Proton radiation devices are used in proton therapy, sometimes referred to as proton radiotherapy and proton beam therapy. Utilizing proton treatment, cancer cells are destroyed. In proton therapy, a beam of protons is directed towards the tumors using proton accelerators. Protons are ionized protons that damage cells' DNA and cause cell death by interfering with it.
Equipment for proton therapy is expensive and takes up a lot of space. It includes electro-magnets, accelerators, gantries, nozzles, and patient rooms. High-energy beams are used in proton treatment, also known as proton radiation, to treat malignancies. A precise dose of high-energy radiation is kept inside the target tumor using this procedure.
The majority of the time, it is used in the treatment of malignant growth therapy. X-beam radiation is dissipated by protons, ensuring less damage to the surrounding healthy tissues. Radiation therapy called proton therapy is most frequently used to treat cancer. When compared to conventional radiation therapy, it offers important advantages in terms of effectiveness and limited side effects.
It is a simple, safe procedure that maintains patients' happiness and enables them to quickly resume routine exercises. It enables medical professionals to administer full or greater therapy doses that completely eradicate the primary tumor spot without seriously harming surrounding healthy tissue or organs.
The COVID-19 pandemic has affected the medical equipment sector globally, especially particle treatment devices. The administration of particle treatment procedures during the COVID-19 pandemic varies greatly from location to region. The temporary deferral of several elective surgeries is anticipated to affect the market for proton therapy as governments and authorities work to guarantee that resources are available for COVID-19 patients. It is predicted to increase the worldwide cancer burden. The delay in diagnosis and treatment procedures is to blame for this.
Proton treatment has seen considerable technological breakthroughs in recent years. These developments have aided manufacturers in creating less invasive, more effective, and regulated proton treatment systems that also cause less radiation exposure to healthy tissues and have fewer adverse effects. More precisely targets cancer cells and tumors. A less amount of energy is produced, and there is a smaller exit dose, lowering the possibility of harm to the nearby healthy tissues and organs.
The increasing number and size of investments made in the healthcare sector by governments of various nations is one of the key drivers fuelling the market's expansion. Due to their rapid economic growth and rising healthcare costs, it is projected that the availability of high-quality healthcare would increase in several developing countries. This is regarded as a promising sign of growth for the proton therapy sector. The rising incidence of cancer in these countries has increased the need for various radiation therapies and equipment.
The inability to distinguish tumors from healthy normal tissue and to visualize them during proton treatment procedures is one of the biggest problems encountered. It becomes extremely challenging to only radiate the malignant protrusion without damaging the surrounding tissues, though, because tumors can change their structure regularly. Radiologists place a safety margin around the tumor to reduce this. Additionally, it becomes imperative to restrict the radiation dose range to reduce the harm to the adjacent healthy tissue, which raises the number of treatment cycles required to destroy tumorous cells.
Based on the Product Type, the Proton Therapy Market is segmented into Accelerator, Beam Transport systems, Beam Delivery systems, Nozzle and Image Viewers, and Patient Positioning System. The accelerator segment garnered the largest revenue share in the proton therapy market in 2021. Proton therapy market growth is further aided by the rising incidence of cancer, cost advantages over imported radioactive tracers, and accessibility of cutting-edge diagnostic tools. Starting with a hydrogen atom, the accelerator splits it apart, separates the proton from the electron, and then accelerates the isolated proton to carry as much energy as is safe.
On the basis of Indication, the Proton Therapy Market is divided into Head and Neck Cancer, CNS Cancer, Prostate Cancer, Breast Cancer, and Others. The head and neck cancer segment witnessed a significant revenue share in the proton therapy market in 2021. Since proton particles do not generate exit dosage, normal tissues located far from the tumor can be spared during proton therapy. Due to the anatomical restrictions present in almost all cancers in the head and neck region, this is very helpful for these tumors.
By End-User, the Proton Therapy Market is divided into Hospitals, Proton Therapy Centers, and Others. The hospital segment procured the highest revenue share in the proton therapy market in 2021. Due to the rise in the prevalence of cancer, improvements in the hospital infrastructure, the use of high-tech equipment, and increased self-awareness about diseases, it is anticipated that this trend will continue during the projected period.
| Report Attribute | Details |
|---|---|
| Market size value in 2021 | USD 428.7 Million |
| Market size forecast in 2028 | USD 963.6 Million |
| Base Year | 2021 |
| Historical Period | 2018 to 2020 |
| Forecast Period | 2022 to 2028 |
| Revenue Growth Rate | CAGR of 12.5% from 2022 to 2028 |
| Number of Pages | 244 |
| Number of Tables | 389 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Product Type, Indication, End User, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the Proton Therapy Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region acquired the largest revenue share in the proton therapy market in 2021. During the foreseeable term, dominance is anticipated to persist. This was ascribed to a strong healthcare system, a growth in elderly patients, favorable reimbursement regulations in the healthcare system, and an increase in the number of healthcare facilities that provide proton treatment.
Free Valuable Insights: Global Proton Therapy Market size to reach USD 963.6 Million by 2028
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.
By Product Type
By Indication
By End User
By Geography
The Proton Therapy Market size is projected to reach USD 963.6 million by 2028.
Benefits of proton therapy compared to particle therapy are driving the market in coming years, however, Tumors are difficult to see during proton treatment operations restraints the growth of the market.
Toshiba Corporation, Siemens Healthineers AG (Siemens AG), Ion Beam Applications SA, Hitachi, Ltd., Mirion Technologies, Inc., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Corporation and Optivus Proton Therapy, Inc.
The expected CAGR of the Proton Therapy Market is 12.5% from 2022 to 2028.
The CNS Cancer market is leading the Global Proton Therapy Market by Indication in 2021; thereby, achieving a market value of $354 million by 2028.
The North America market dominated the Global Proton Therapy Market by Region in 2021 thereby, achieving a market value of $370.6 million by 2028.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 